Press release
Niemann-Pick-Disease Pipeline Outlook, Clinical Trials, FDA Approvals, and Companies 2024 (Updated)
Niemann-Pick-Disease Pipeline
Key Takeaways from the Niemann-Pick-Disease Pipeline Report
• DelveInsight's Niemann-Pick-Disease pipeline report depicts a robust space with 20+ active players working to develop 20+ pipeline therapies for Niemann-Pick-Disease treatment.
• The leading companies working in the Niemann-Pick-Disease Market include Orphazyme, Cyclo Therapeutics, Mandos LLC, IntraBio, E-scape Bio, Scenic Biotech, Synaptogenix, Evox Therapeutics, StrideBio, SOM Biotech, ENDECE, Oraxion Therapeutics, Polaryx Therapeutics, and others.
• Promising Niemann-Pick-Disease Pipeline Therapies in the various stages of development include N-Acetyl-L-Leucine, Hydroxypropyl-beta-cyclodextrin, arimoclomol, IB1001, and others.
• April 2024: Sanofi- A Prospective Observational Study to Assess the Long-term Safety and Immunogenicity of Olipudase Alfa Therapy During Routine Clinical Care in Pediatric Patients Less Than 2 Years of Age With Acid Sphingomyelinase Deficiency.
Request a sample and discover the recent advances in Niemann-Pick-Disease Treatment Drugs @ Niemann-Pick-Disease Pipeline Report- https://www.delveinsight.com/report-store/niemann-pick-disease-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr
In the Niemann-Pick-Disease pipeline report, detailed description of the drug is given which includes mechanism of action of the drug, clinical studies, NDA approvals (if any), and product development activities comprising the technology, Niemann-Pick-Disease collaborations, licensing, mergers and acquisition, funding, designations and other product related details.
Niemann-Pick-Disease Overview
Niemann-Pick Diseases (NPD) include heterogeneous groups of autosomal recessive lysosomal lipid storage disorders, with common features of hepatosplenomegaly and sphingomyelin storage in reticuloendothelial and parenchymal tissues, with or without neurological involvement. Niemann-Pick Disease (NPD) is classified as Niemann-Pick Disease type A, Niemann-Pick Disease type B, and Niemann-Pick Disease type C.
Find out more about Niemann-Pick-Disease Therapeutics Assessment @ Niemann-Pick-Disease Preclinical and Discovery Stage Products- https://www.delveinsight.com/sample-request/niemann-pick-disease-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr
Niemann-Pick-Disease Emerging Drugs Profile
• Arimoclomol: Orphazyme
• Trappsol Cyclo: Cyclo Therapeutics
• VTS-270: Mandos LLC
• ESB1609: E-scape Bio
Niemann-Pick-Disease Pipeline Therapeutics Assessment
There are approx. 20+ key companies which are developing the Niemann-Pick-Disease therapies. The Niemann-Pick-Disease companies which have their Niemann-Pick-Disease drug candidates in the most advanced stage, i.e. Pre-Registration, Orphazyme.
Learn more about the emerging Niemann-Pick-Disease Pipeline Therapies @ Niemann-Pick-Disease Clinical Trials Assessment- https://www.delveinsight.com/sample-request/niemann-pick-disease-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr
Scope of the Niemann-Pick-Disease Pipeline Report
• Coverage- Global
• Niemann-Pick-Disease Therapeutic Assessment by Product Type: Mono, Combination, Mono/Combination
• Niemann-Pick-Disease Therapeutic Assessment by Clinical Stages: Discovery, Pre-clinical, Phase I, Phase II, Phase III
• Niemann-Pick-Disease Companies- Orphazyme, Cyclo Therapeutics, Mandos LLC, IntraBio, E-scape Bio, Scenic Biotech, Synaptogenix, Evox Therapeutics, StrideBio, SOM Biotech, ENDECE, Oraxion Therapeutics, Polaryx Therapeutics, and others.
• Niemann-Pick-Disease Pipeline Therapies- N-Acetyl-L-Leucine, Hydroxypropyl-beta-cyclodextrin, arimoclomol, IB1001, and others.
Dive deep into rich insights for new drugs for Niemann-Pick-Disease treatment, Visit @ Niemann-Pick-Disease Market Drivers and Barriers, and Future Perspective- https://www.delveinsight.com/sample-request/niemann-pick-disease-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr
Table of Content
1. Introduction
2. Executive Summary
3. Niemann-Pick-Disease: Overview
4. Pipeline Therapeutics
5. Therapeutic Assessment
6. Niemann-Pick-Disease- DelveInsight's Analytical Perspective
7. Late Stage Products (Pre-Registration)
8. Arimoclomol: Orphazyme
9. Drug profiles in the detailed report…..
10. Mid Stage Products (Phase II)
11. Drug name : Company name
12. Drug profiles in the detailed report…..
13. Early Stage Products (Phase I)
14. ESB1609: E-scape Bio
15. Drug profiles in the detailed report…..
16. Preclinical and Discovery Stage Products
17. Drug name : Company name
18. Drug profiles in the detailed report…..
19. Inactive Products
20. Niemann-Pick-Disease Key Companies
21. Niemann-Pick-Disease Key Products
22. Niemann-Pick-Disease- Unmet Needs
23. Niemann-Pick-Disease- Market Drivers and Barriers
24. Niemann-Pick-Disease- Future Perspectives and Conclusion
25. Niemann-Pick-Disease Analyst Views
26. Niemann-Pick-Disease Key Companies
27. Appendix
For further information on the Niemann-Pick-Disease pipeline therapeutics, reach out to Niemann-Pick-Disease Unmet Needs and Analyst Views- https://www.delveinsight.com/sample-request/niemann-pick-disease-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr
List of Important Links-
http://demo.advised360.com/read-blog/154799
https://thehealthbridges.com/read-blog/19127
https://app.talkshoe.com/user/joneswilliam/about#google_vignette
https://www.vaca-ps.org/blogs/142022/The-Evolving-Landscape-of-Healthcare-Business-Consulting-Services
https://www.anobii.com/en/01d38d0b9694756e64/profile/activity
https://myanimelist.net/profile/dennydonesgerman
https://forum.pivx.org/threads/healthcare-business-consulting-services-navigating-complexity-in-modern-healthcare.2035/
https://pubhtml5.com/homepage/npvs/
https://b31.org.uk/author/anniesmith9/
https://fairygodboss.com/users/profile/Ix-vMa09gj/Annie-Smith
https://forum.completefrance.com/index.php?/topic/71194-key-areas-of-focus-in-healthcare-consulting-services/
https://educatorpages.com/site/kelleadvin/pages/blog?
https://offgridworld.com/author/anniejones9/
https://www.openhumans.org/member/me/
https://findpenguins.com/5zphebtv0zouo
http://jobs.emiogp.com/author/williamsmith9/
https://www.shippingexplorer.net/en/user/williamsmith9/88249
https://wakelet.com/@DennyDones813
https://startupxplore.com/en/person/denny-dones
https://www.nfpjobs.com.au/employers/1939365-delveinsight
https://community.hodinkee.com/members/dennydoness
https://jobs.mikeroweworks.org/employers/1930150-delveinsight
https://www.social-vape.com/read-blog/132516
https://codex.core77.com/users/dennydones9
https://www.newjerseyhunter.com/members/dennydones1.84566/#about
https://au.blurb.com/user/dennydones9?profile_preview=true
https://trabajo.merca20.com/author/kelleadvin/
https://www.atlasobscura.com/users/dennydones1
https://www.mixcloud.com/dennydones1/
https://www.designspiration.com/ybhardwaj/
About Us
DelveInsight is a leading healthcare-focused market research and consulting firm that provides clients with high-quality market intelligence and analysis to support informed business decisions. With a team of experienced industry experts and a deep understanding of the life sciences and healthcare sectors, we offer customized research solutions and insights to clients across the globe. Connect with us to get high-quality, accurate, and real-time intelligence to stay ahead of the growth curve.
Company Name: DelveInsight Business Research LLP
Contact Person: Yash Bhardwaj
Email: ybhardwaj@delveinsight.com
Phone: 9650213330
Address: 304 S. Jones Blvd #2432
City: Las Vegas
State: NV
Country: United States
Website:- https://www.delveinsight.com/
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Niemann-Pick-Disease Pipeline Outlook, Clinical Trials, FDA Approvals, and Companies 2024 (Updated) here
News-ID: 3475579 • Views: …
More Releases from DelveInsight Business Research LLP
Scedosporium Infection Market Outlook Report 2032 by DelveInsight | Pfizer, Gile …
DelveInsight's "Scedosporium Infection Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of Scedosporium Infection, historical and forecasted epidemiology as well as the Scedosporium Infection market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom), and Japan.
The Scedosporium Infection market report provides current treatment practices, emerging drugs, Scedosporium Infection market share of the individual therapies, and current and forecasted Scedosporium Infection market size…
Negative Pressure Wound Therapy Systems Market Report by DelveInsight | 3M, Card …
Negative Pressure Wound Therapy Systems Market Report by DelveInsight | 3M, Cardinal Health, ConvaTec Group PLC, DeRoyal Industries, Inc., Devon Group, Medela AG, Smith & Nephew PLC, Mölnlycke Health Care AB, Direct Healthcare Group, Accel-Heal Technologies Ltd., B. Braun Melsungen AG, Lohmann & Rauscher, Cenefom Corp., PAUL HARTMANN Asia-Pacific Ltd., Carilex Medical, Chongqing Sunshine Medical Industry and Trading Co., Ltd., Foryou Medical Electronics Co., Ltd., OncoVista Innovative Therapies, Genadyne, Cork…
SGLT2 Inhibitors Market Report 2032 by DelveInsight | Novo Nordisk, AstraZeneca, …
DelveInsight's "SGLT2 Inhibitors Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of SGLT2 Inhibitors, historical and forecasted epidemiology as well as the SGLT2 Inhibitors market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom), and Japan.
The SGLT2 Inhibitors market report provides current treatment practices, emerging drugs, SGLT2 Inhibitors market share of the individual therapies, and current and forecasted SGLT2 Inhibitors market size…
Metastatic Castration-Resistant Prostate Cancer Market Outlook Report 2032 by De …
DelveInsight's "Metastatic Castration-Resistant Prostate Cancer Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of Metastatic Castration-Resistant Prostate Cancer, historical and forecasted epidemiology as well as the Metastatic Castration-Resistant Prostate Cancer market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom), and Japan.
The Metastatic Castration-Resistant Prostate Cancer market report provides current treatment practices, emerging drugs, Metastatic Castration-Resistant Prostate Cancer market share of the…
More Releases for Disease
Biopharmaceutical Fermentation Market 2022 | Growing Morbidity of Genetic Diseas …
According to Precision Business Insights (PBI), the latest report, the biopharmaceutical fermentation market is expected to be valued at USD 10,302.1 million in 2022, growing at a 4.7% CAGR from 2022 to 2028. The growing prevalence of chronic illness, cancer, cardiac diseases, infectious diseases, antibiotic resistance, autoimmune diseases, etc., globally causes the leaning toward biopharmaceutical products, which show promising results in the research studies. Moreover, new findings by the…
Global Inflammatory Bowel Disease (IBD) Market Key Players Analysis, Disease Ind …
Global Inflammatory Bowel Disease (IBD) Market, valued at USD 210.5 Billion in the year 2020 has been driven by factors such as the increasing prevalence of Ulcerative Colitis and Crohn’s Disease, advances in medical technology, government support for inflammatory bowel disease treatment research, and the ubiquity of anxiety and depression. Moreover, factors such as the irregular food habits, unhealthy lifestyle of people, increased level of pollution and increase in alcohol…
Refsum Disease Industry An Overview of A New Disease - 2018
"Refsum Disease" is a genetic disorder which is inherited as an autosomal recessive trait. The condition is characterized by progressive loss of vision (retinitis pigmentosa), failure of muscle coordination (ataxia), degenerative nerve disease (peripheral neuropathy), and dry, rough, scaly skin (ichthyosis). The accumulation of fatty acid (phytanic acid) in blood plasma and tissues is the main cause of refsum disease. This occurs due to malfunction of the enzyme producing gene…
Gaucher Disease Treatment Market, by Disease Type, Therapy Type
Gaucher disease is an autosomal recessive inherited metabolism disorder where a type of fat (lipid) called glucocerebroside is unable to degrade. Body synthesis enzyme called glucocerebrosidase, which breakdowns and reprocesses glucocerebroside. Gaucher disease is caused by mutations of a single gene called GBA, which leads to very low levels of glucocerebrosidase enzyme leading to low degradation of glucocerebroside. There are three types of Gaucher disease namely: type 1, type 2,…
Autoimmune Disease Diagnostic Market By Disease, Tests Type, Regions, Companies
"The Latest Research Report Autoimmune Disease Diagnostic Market, Global Forecast, By Disease, Tests Type, Regions, Companies provides information on pricing, market analysis, shares, forecast, and company profiles for key industry participants. - MarketResearchReports.biz"
Autoimmune Disease Diagnostic Market is anticipated to exceed US$ 18 Billion, experiencing a significant growth over the forecast period. Autoimmune diseases take place when there is disruption of the usual control process (immune system of the body becomes…
Chagas Disease (Infectious Disease) Pipeline Forecast Report, H1, 2017 [MRH]
Market Research Hub's Pharmaceutical and Healthcare latest pipeline guide Chagas Disease - Pipeline Review, H1 2017, provides comprehensive information on the therapeutics under development for Chagas Disease Market (Infectious Disease), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and…
